Dataset on the effects of CYB5D2 on the distribution of HeLa cervical cancer cell cycle
Yanyun Xie,
Yen Ting Shen,
Anil Kapoor,
Diane Ojo,
Fengxiang Wei,
Jason De Melo,
Xiaozeng Lin,
Nicholas Wong,
Judy Yan,
Lijian Tao,
Pierre Major,
Damu Tang
Affiliations
Yanyun Xie
Division of Nephrology, Department of Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, PR China; Division of Nephrology, Department of Medicine, McMaster University, Canada; Father Sean O’Sullivan Research Institute, Canada; The Hamilton Center for Kidney Research, St. Joseph’s Hospital, Canada
Yen Ting Shen
Division of Nephrology, Department of Medicine, McMaster University, Canada; Father Sean O’Sullivan Research Institute, Canada; The Hamilton Center for Kidney Research, St. Joseph’s Hospital, Canada
Anil Kapoor
Father Sean O’Sullivan Research Institute, Canada; Department of Surgery, McMaster University, Hamilton, Ontario, Canada
Diane Ojo
Division of Nephrology, Department of Medicine, McMaster University, Canada; Father Sean O’Sullivan Research Institute, Canada; The Hamilton Center for Kidney Research, St. Joseph’s Hospital, Canada
Fengxiang Wei
The Genetics Laboratory, Institute of Women and Children’s Health, Longgang District, Shenzhen, Guangdong, PR China; ZhunYi Medical University, Zhunyi, Guizhou, PR China
Jason De Melo
Division of Nephrology, Department of Medicine, McMaster University, Canada; Father Sean O’Sullivan Research Institute, Canada; The Hamilton Center for Kidney Research, St. Joseph’s Hospital, Canada
Xiaozeng Lin
Division of Nephrology, Department of Medicine, McMaster University, Canada; Father Sean O’Sullivan Research Institute, Canada; The Hamilton Center for Kidney Research, St. Joseph’s Hospital, Canada
Nicholas Wong
Division of Nephrology, Department of Medicine, McMaster University, Canada; Father Sean O’Sullivan Research Institute, Canada; The Hamilton Center for Kidney Research, St. Joseph’s Hospital, Canada
Judy Yan
Division of Nephrology, Department of Medicine, McMaster University, Canada; Father Sean O’Sullivan Research Institute, Canada; The Hamilton Center for Kidney Research, St. Joseph’s Hospital, Canada
Lijian Tao
Division of Nephrology, Department of Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, PR China
Pierre Major
Division of Medical Oncology, Department of Oncology, McMaster University, Hamilton, Ontario, Canada
Damu Tang
Division of Nephrology, Department of Medicine, McMaster University, Canada; Father Sean O’Sullivan Research Institute, Canada; The Hamilton Center for Kidney Research, St. Joseph’s Hospital, Canada; Corresponding author at: Division of Nephrology, Department of Medicine, McMaster University, Canada.
We have recently reported that CYB5D2 plays a role in suppression of cervical cancer tumorigenesis, “CYB5D2 displays tumor suppression activities towards cervical cancer” [1]. We provide the accompany data here describing the effects of CYB5D2 overexpression and addition of recombinant CYB5D2 on HeLa cell cycle distribution. Furthermore, we will present the conditions used to specifically determine CYB5D2 expression in primary cervical and cervical cancer tissues using immunohistochemistry (IHC) and the patient cohort involved in assessing the CYB5D2 protein levels in primary cervical and cervical cancer tissues.
